180 related articles for article (PubMed ID: 15633577)
1. [Prevalence for seropositivity for HIV, hepatitis B and hepatitis C in blood donors].
Rivera-López MR; Zavala-Méndez C; Arenas-Esqueda A
Gac Med Mex; 2004; 140(6):657-60. PubMed ID: 15633577
[TBL] [Abstract][Full Text] [Related]
2. [Prevalence of VHB and VHC serological markers among blood donors in the capital state of Veracruz, Mexico].
Valerio-Ureña J; Vásquez-Fernández F; Pérez-Sosa JA; Cortazar-Benitez LF; Chávez-Tapia NC; Ruvalcaba-Rojas OA; Torres-Medina V; Ocejo-Rodríguez A
Gac Med Mex; 2009; 145(3):183-7. PubMed ID: 19685823
[TBL] [Abstract][Full Text] [Related]
3. The prevalence of positive hepatitis B, hepatitis C, and HIV serology in cornea donors prescreened by medical and social history in Ontario, Canada.
Armstrong SA; Gangam N; Chipman ML; Rootman DS
Cornea; 1997 Sep; 16(5):512-6. PubMed ID: 9294680
[TBL] [Abstract][Full Text] [Related]
4. [Seroprevalence of hepatitis C virus (HCV) in Senegalease blood donors].
Dieye TN; Gadji M; Cisse Y; Diallo TA; Toure Falla O; Diop S; Diallo S; Thiam D; Diakhate L
Dakar Med; 2006; 51(1):47-52. PubMed ID: 16924850
[TBL] [Abstract][Full Text] [Related]
5. [Seropositivity of HIV, HBV, HCV and Treponema pallidum in blood donors in southeast Mexico].
García-Montalvo BM
Rev Invest Clin; 2006; 58(6):567-72. PubMed ID: 17432288
[TBL] [Abstract][Full Text] [Related]
6. [The prevalence of hepatitis B and C in blood donors in a 3rd-level hospital of Mexico City].
Méndez-Sánchez N; Baptista-González H; Sánchez-Gómez RH; Bordes-Aznar J; Uribe-Esquivel M
Salud Publica Mex; 1999; 41(6):475-8. PubMed ID: 10634078
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and screening costs of hepatitis C virus among Ugandan blood donors.
Hladik W; Kataaha P; Mermin J; Purdy M; Otekat G; Lackritz E; Alter MJ; Downing R
Trop Med Int Health; 2006 Jun; 11(6):951-4. PubMed ID: 16772018
[TBL] [Abstract][Full Text] [Related]
8. Impact of individual-donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa.
Vermeulen M; Lelie N; Sykes W; Crookes R; Swanevelder J; Gaggia L; Le Roux M; Kuun E; Gulube S; Reddy R
Transfusion; 2009 Jun; 49(6):1115-25. PubMed ID: 19309474
[TBL] [Abstract][Full Text] [Related]
9. [Prevalences of HIV, hepatitis B and hepatitis C in blood donors in the Republic of Djibouti].
Dray X; Dray-Spira R; Bronstein JA; Mattera D
Med Trop (Mars); 2005; 65(1):39-42. PubMed ID: 15903075
[TBL] [Abstract][Full Text] [Related]
10. [Retrospective evaluation of HBsAg, anti-HCV, anti-HIV and syphilis reagin antibody seropositivity in blood donors at the Trabzon Farabi Hospital].
Aydin F; Cubukçu K; Yetişkul S; Yazici Y; Kaklikkaya N
Mikrobiyol Bul; 2002 Jan; 36(1):85-90. PubMed ID: 12476771
[TBL] [Abstract][Full Text] [Related]
11. [Seroprevalence of hepatitis B and C virus, human immunodeficiency virus and syphilis in the blood donors].
Mutlu B; Meriç M; Willke A
Mikrobiyol Bul; 2004 Oct; 38(4):445-8. PubMed ID: 15700672
[TBL] [Abstract][Full Text] [Related]
12. Use of replacement blood donors to study the epidemiology of major blood-borne viruses in the general population of Maputo, Mozambique.
Cunha L; Plouzeau C; Ingrand P; Gudo JP; Ingrand I; Mondlane J; Beauchant M; Agius G
J Med Virol; 2007 Dec; 79(12):1832-40. PubMed ID: 17935167
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and trends of markers of hepatitis C virus, hepatitis B virus and human immunodeficiency virus in Delhi blood donors: a hospital based study.
Pahuja S; Sharma M; Baitha B; Jain M
Jpn J Infect Dis; 2007 Nov; 60(6):389-91. PubMed ID: 18032841
[TBL] [Abstract][Full Text] [Related]
14. [The prevalence of markers for hepatitis A, B and C in a hospital in Mexico].
Souto-Meiriño CA; Simón-Domínguez J; Pulido-Priego Mde L; Hernández-Pérez A; García-Hernández IC; del Río-Chiriboga CA
Salud Publica Mex; 1994; 36(3):257-62. PubMed ID: 7940005
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of hepatitis B and hepatitis C virus infections in potential blood donors in rural Cambodia.
Ol HS; Bjoerkvoll B; Sothy S; Van Heng Y; Hoel H; Husebekk A; Gutteberg T; Larsen S; Husum H
Southeast Asian J Trop Med Public Health; 2009 Sep; 40(5):963-71. PubMed ID: 19842380
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of viral markers among first-time Arab blood donors in Kuwait.
Ameen R; Sanad N; Al-Shemmari S; Siddique I; Chowdhury RI; Al-Hamdan S; Al-Bashir A
Transfusion; 2005 Dec; 45(12):1973-80. PubMed ID: 16371052
[TBL] [Abstract][Full Text] [Related]
17. Comparisons of hepatitis B and C and HIV prevalence rates.
Soldan K; Ramsay M
J Infect; 2000 Jul; 41(1):113. PubMed ID: 10942651
[No Abstract] [Full Text] [Related]
18. [Short communication: hepatitis B, hepatitis C and human immunodeficiency virus seropositivities in women admitted to Sanliurfa Gynecology and Obstetrics Hospital].
Tekay F; Ozbek E
Mikrobiyol Bul; 2006 Oct; 40(4):369-73. PubMed ID: 17205695
[TBL] [Abstract][Full Text] [Related]
19. Detection of HIV-1 infection in blood donors during the immunological window period using the nucleic acid-amplification technology.
Scuracchio PS; Poli MC; Lemos MM; Oliveira Filho AG; Salles NA; Chamone DA; Magri M; Cavalcante NJ; Collela R
Transfus Med; 2007 Jun; 17(3):200-4. PubMed ID: 17561863
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of infection with hepatitis B and C virus and coinfection with HIV in medical inpatients in Malawi.
Nyirenda M; Beadsworth MB; Stephany P; Hart CA; Hart IJ; Munthali C; Beeching NJ; Zijlstra EE
J Infect; 2008 Jul; 57(1):72-7. PubMed ID: 18555534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]